Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.26 USD | +0.71% | +3.65% | +17.03% |
Apr. 29 | MannKind Gets FDA Approval to Begin Phase 3 Trial of Lung Disease Treatment | MT |
Apr. 29 | MannKind Gets FDA Clearance for Clofazimine IND Application | DJ |
- Stock Market
- Equities
- MNKD Stock
- News MannKind Corporation
- Trading Ideas